Spravato (esketamine) Treatment Proven Effective for
Treatment-Resistant Depression

You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).

SPRAVATO® is the only FDA-approved nasal spray for TRD

  • SPRAVATO® is an NMDA receptor antagonist that is believed to work differently by acting on a pathway in the brain that affects glutamate

Reach out to our Spravato Administrator Today!